Nocturia Epidemiology Forecast to 2030 by DelveInsight

 

Nocturia Epidemiology” report has been added to DelveInsight

Nocturia Overview

The need for a patient to get up at night on a regular basis to urinate is called Nocturia. To be considered as a nocturnal void, a period of sleep must precede and follow the urinary episode. This means that when identifying nocturia episodes, the first morning void is ignored.

Nocturia Epidemiology Forecast

DelveInsight’s ‘Nocturia – Epidemiology Forecast to 2030‘ report delivers an in-depth understanding of the disease, historical and forecasted Nocturia epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

Request free sample copy- https://www.delveinsight.com/sample-request/nocturia-epidemiology-forecast

Regions covered

  • The United States
  • EU5 (Germany, France, Italy, Spain, and the United Kingdom)
  • Japan

Nocturia Symptoms

Some of the signs and symptoms of nocturia are as follows: Urinating more than once during the night, and increased volume of urine (if polyuria is present). In addition, the patient often feels exhausted and sleepy even after waking up. This occurs because repeated urination will interrupt the sleep cycle.

Nocturia Epidemiology Insights

Nocturia is often identified as the most unpleasant of all urinary symptoms, as well as one of the most popular. It is estimated that it affects ~50 million people in the United States, with 10 million actually diagnosed with nocturia

Key facts of Nocturia report

  • The prevalence of nocturia rises with age. There is a trend for young women to have a higher prevalence than young men, which is changed later in life. By age 80, majority of people will rise at least once per night to void.
  • A retrospective modelling study was conducted by Weidlich et al. (2017), to estimate the prevalence-based cost of illness imposed by nocturia (≥2 nocturnal voids per night) in Germany, Sweden, and the UK in an average year. The findings of this study showed that in an average year, there are an estimated 12.5 and 8.6 million patients’ ≥20 years of age with nocturia in Germany and the UK, respectively.
  • According to DelveInsight. Nocturia affects both men and women depending upon their age and causes.

Nocturia Epidemiology Segmentation

  • Total prevalent cases
  • Total type-specific prevalent cases
  • Total diagnosed prevalent cases
  • Total age-specific prevalent cases
  • Treated cases

Nocturia Epidemiology Perspective

The Nocturia epidemiology division provides insights about historical and current patient pool and forecasted trend for every seven major countries. The Nocturia epidemiology data are studied through all possible division to give a better understanding of the Disease scenario in 7MM. The Nocturia epidemiology segment covers the epidemiology data in the US, EU5 countries (Germany, Spain, Italy, France, and the UK), and Japan from 2017 to 2030. It also helps to recognize the causes of current and forecasted trends by exploring numerous studies, survey reports and views of key opinion leaders.

Nocturia Report Scope

  • The Nocturia report covers a detailed overview explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns
  • The Nocturia Epidemiology Report and Model provide an overview of the risk factors and global trends of Nocturia in the seven major markets (7MM:US, France, Germany, Italy, Spain, UK, and Japan)
  • The report provides insight about the historical and forecasted patient pool of Nocturia in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan
  • The report helps to recognize the growth opportunities in the 7MM with respect to the patient population
  • The report assesses the disease risk and burden and highlights the unmet needs of Nocturia
  • The report provides the segmentation of the Nocturia epidemiology

Request free sample copy- https://www.delveinsight.com/sample-request/nocturia-epidemiology-forecast

Table of content

  1. Key Insights
  2. Executive Summary of Nocturia
  3. Nocturia: Disease Background and Overview
  4. Patient Journey
  5. Epidemiology and Patient Population
  6. Treatment Algorithm, Current Treatment, and Medical Practices
  7. KOL Views
  8. Unmet Needs
  9. Appendix
  10. DelveInsight Capabilities
  11. Disclaimer
  12. About DelveInsight

Why should you buy this report?

  • Develop business strategies by understanding the trends shaping and driving the global Nocturia market
  • Quantify patient populations in the global Nocturia market to improve product design, pricing, and launch plans
  • Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for Nocturia therapeutics in each of the markets covered
  • Understand the magnitude of Nocturia population by its epidemiology
  • The Nocturia Epidemiology Model developed by DelveInsight is easy to navigate, interactive with dashboards, and epidemiology based with transparent and consistent methodologies. Moreover, the model supports data presented in the report and showcases disease trends over 11-year forecast period using reputable sources

Related Reports

View Latest Reports

ADHD Market

DelveInsight’s Attention-deficit/hyperactivity disorder (ADHD) Market Insights, Epidemiology and Market Forecast – 2030 report provides the detailed overview of the disease and in depth understanding of historical and forecasted epidemiology.

Farber’s Disease Market

DelveInsight’s Farber’s Disease Market Insights, Epidemiology and Market Forecast – 2030 report provides an in depth understanding of historical.

Transverse Myelitis Market

DelveInsight’s Transverse Myelitis Market Insights, Epidemiology and Market Forecast – 2030 report provides the detailed overview of the disease and in depth understanding of historical and forecasted epidemiology.

Opioid-related Disorders Market

DelveInsight’s “Opioid-related Disorders Market Insights, Epidemiology, and Market Forecast-2030” report delivers an in-depth understanding historical and forecasted epidemiology

Systemic Inflammatory Response Syndrome Market

DelveInsight’s “Opioid-related Disorders Market Insights, Epidemiology, and Market Forecast-2030” report delivers an in-depth understanding market data

Paranasal Sinus Cancer Market

Paranasal Sinus Cancer market report provides current treatment practices, emerging drugs, market share of the individual therapies, current and forecasted from 2017 to 2030 segmented by 7MM.

Cone Rod Dystrophy Market

DelveInsight’s Cone Rod Dystrophy – Market Insights, Epidemiology and Market Forecast – 2030 report provides the detailed overview of the disease and in depth understanding of historical and forecasted epidemiology.

Smallpox Market

DelveInsight’s Smallpox – Market Insights, Epidemiology and Market Forecast – 2030 report provides the detailed overview of the disease and in depth understanding of historical and forecasted epidemiology.

Shingles Market

DelveInsight’s Shingles- Market Insights, Epidemiology and Market Forecast – 2030 report provides an in depth understanding of historical.

Schistosomiasis Market

DelveInsight’s Schistosomiasis Market Insights, Epidemiology and Market Forecast – 2030 report provides the detailed overview of the disease and in depth understanding of historical and forecasted epidemiology.

Parainfluenza Virus Infection Market

DelveInsight’s Parainfluenza Virus Infection – Market Insights, Epidemiology and Market Forecast – 2030 report provides a detailed understanding of historical and forecasted epidemiology.

About Us

DelveInsight is a Business Consulting and Market research company, providing expert business solutions for life science vertical and offering quintessential advisory services in the areas of R&D, Strategy Formulation, Operations, Competitive Intelligence, Competitive Landscaping, and Mergers & Acquisitions.

Contact Us 

Shruti Thakur

[email protected]

+91-9650213330

https://goodnewsgum.com/

Leave a Reply

Your email address will not be published. Required fields are marked *